Cellmig Biolabs Information

Creating Next-Generation Medicines for Cancer Therapy Cellmig, a leading global biopharmaceutical company, is committed to translating revolutionary discoveries into pioneering medicines and medical devices for terminating cancer lethality, saving cancer patients’ lives, and improving the quality of patients worldwide.

Website	https://www.cellmig.com
Revenue	$5 million
Employees	View employees
Founded	2016
Address	85 Bolton St, Cambridge, Massachusetts 02140, US
Phone	+1 617-714-4129
Industry	Biotechnology Research, Biotechnology, Pharmaceuticals, Healthcare
Keywords	Cancer Treatment, Cancer Drugs, Cancer Therapeutics, Biotechnology, Oncology, Pharmaceutical, Biopharmaceutical, Oncology Research, Immunotherapy, Novel Therapeutics, Drug Discovery, Precision Medicine, Targeted Therapy, Cancer Research, New Drug Development, Cell Therapy, Clinical Trials, Gene Therapy, Pharmaceutical Research, Medical Devices
Competitors	Lonza, Thermo Fisher Scientific, Merck Group, Miltenyi Biotec, STEMCELL Technologies, Genentech, R&D Systems, Cell Signaling Technology (CST), Fisher BioServices, Corning Incorporated +34 more (view full list)
SIC	SIC Code 873 Companies, SIC Code 87 Companies
NAICS	NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies